Informa plc (LON:INF) Receives Consensus Rating of “Moderate Buy” from Analysts

Informa plc (LON:INF) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is GBX 1,105.

Several brokerages have commented on INF. JPMorgan Chase & Co. lowered their target price on shares of Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating for the company in a research note on Monday. UBS Group reissued a “buy” rating and issued a GBX 1,055 price target on shares of Informa in a report on Friday, November 7th. Panmure Gordon reaffirmed a “buy” rating and set a GBX 1,200 price objective on shares of Informa in a research note on Wednesday, November 19th. Deutsche Bank Aktiengesellschaft lifted their target price on Informa from GBX 1,000 to GBX 1,140 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Finally, Citigroup initiated coverage on Informa in a report on Monday. They issued a “neutral” rating and a GBX 975 price target for the company.

Informa Trading Down 1.6%

Shares of Informa stock traded down GBX 14.20 during trading on Monday, reaching GBX 886.80. 2,321,778 shares of the company were exchanged, compared to its average volume of 3,303,222. The business has a 50-day moving average price of GBX 918.36 and a 200-day moving average price of GBX 897.21. The firm has a market capitalization of £11.34 billion, a price-to-earnings ratio of 161.24, a P/E/G ratio of 0.75 and a beta of 1.12. The company has a quick ratio of 1.70, a current ratio of 0.56 and a debt-to-equity ratio of 31.98. Informa has a twelve month low of GBX 634.20 and a twelve month high of GBX 1,000.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.